CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Grant or award EVP, Pres., Novocure Oncology acquired 179,426 shares (grant or award)
- 4 Open-market sale Director sold 999 shares at $17.28 ($17,259)
- 4 Open-market sale Director sold 999 shares at $17.31 ($17,297)
- 4 Open-market sale Director sold 999 shares at $17.19 ($17,176)
- 4 Open-market sale Director sold 999 shares at $17.32 ($17,299)
- 4 Open-market sale Director sold 999 shares at $17.26 ($17,247)
- 4 Open-market sale Director sold 999 shares at $17.29 ($17,269)
- 4 Open-market sale Director sold 999 shares at $17.35 ($17,329)
- 4 Open-market sale Director sold 999 shares at $17.30 ($17,280)
- 4 Planned sale EVP, Pres., Novocure Oncology sold 30,196 shares at an average $17.50 ($528,413)
- 4 Open-market sale Chief Operating Officer sold 592 shares at $17.91 ($10,604)
- 4 Grant or award Chief Financial Officer acquired 54,975 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 54,975 shares (grant or award)
- 4 Grant or award General Counsel acquired 54,975 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 54,975 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 54,975 shares (grant or award)
- 4 Grant or award EVP, Pres., Novocure Oncology acquired 54,975 shares (grant or award)
Page 4 of 39 · 780 filings